[go: up one dir, main page]

FR2839309B1 - Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation - Google Patents

Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation

Info

Publication number
FR2839309B1
FR2839309B1 FR0205573A FR0205573A FR2839309B1 FR 2839309 B1 FR2839309 B1 FR 2839309B1 FR 0205573 A FR0205573 A FR 0205573A FR 0205573 A FR0205573 A FR 0205573A FR 2839309 B1 FR2839309 B1 FR 2839309B1
Authority
FR
France
Prior art keywords
chemotheks
hexahydro
pyridazine
medicaments
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0205573A
Other languages
English (en)
Other versions
FR2839309A1 (fr
Inventor
Neerja Bhatnagar
Jean Francois Gourvest
Jacques Mauger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0205573A priority Critical patent/FR2839309B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to JP2004503450A priority patent/JP2005529147A/ja
Priority to EP03749907A priority patent/EP1503991A1/fr
Priority to PCT/FR2003/001335 priority patent/WO2003095433A1/fr
Priority to MXPA04010129A priority patent/MXPA04010129A/es
Priority to AU2003246868A priority patent/AU2003246868A1/en
Priority to CA002485083A priority patent/CA2485083A1/fr
Priority to BR0304666-4A priority patent/BR0304666A/pt
Publication of FR2839309A1 publication Critical patent/FR2839309A1/fr
Application granted granted Critical
Publication of FR2839309B1 publication Critical patent/FR2839309B1/fr
Priority to US10/979,679 priority patent/US7034022B2/en
Priority to IL16499404A priority patent/IL164994A0/xx
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0205573A 2002-05-03 2002-05-03 Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation Expired - Fee Related FR2839309B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0205573A FR2839309B1 (fr) 2002-05-03 2002-05-03 Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation
BR0304666-4A BR0304666A (pt) 2002-05-03 2003-04-29 Derivados do ácido hexa-hidro-piridazina-3-carboxìlico, quimiotecas que os contém, sua utilização como medicamentos, composições farmacêuticas que os contêm e seus procesos de preparo
PCT/FR2003/001335 WO2003095433A1 (fr) 2002-05-03 2003-04-29 Derives de l'acide hexahydro-pyridazine-3-carboxylique, compositions pharmaceutiques les contenant et leurs procedes de preparation
MXPA04010129A MXPA04010129A (es) 2002-05-03 2003-04-29 Derivados de acido hexahidro-piridazin-3-carboxilico, composiciones farmaceuticas que los contienen y procedimientos para su preparacion.
AU2003246868A AU2003246868A1 (en) 2002-05-03 2003-04-29 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
CA002485083A CA2485083A1 (fr) 2002-05-03 2003-04-29 Derives de l'acide hexahydro-pyridazine-3-carboxylique, compositions pharmaceutiques les contenant et leurs procedes de preparation
JP2004503450A JP2005529147A (ja) 2002-05-03 2003-04-29 ヘキサヒドロピリダジン−３−カルボン酸誘導体、該誘導体を含有する医薬組成物およびその製法
EP03749907A EP1503991A1 (fr) 2002-05-03 2003-04-29 Derives de l'acide hexahydro-pyridazine-3-carboxylique, compositions pharmaceutiques les contenant et leurs procedes de preparation
US10/979,679 US7034022B2 (en) 2002-05-03 2004-11-02 Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation
IL16499404A IL164994A0 (en) 2002-05-03 2004-11-02 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0205573A FR2839309B1 (fr) 2002-05-03 2002-05-03 Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation

Publications (2)

Publication Number Publication Date
FR2839309A1 FR2839309A1 (fr) 2003-11-07
FR2839309B1 true FR2839309B1 (fr) 2004-07-23

Family

ID=29226178

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0205573A Expired - Fee Related FR2839309B1 (fr) 2002-05-03 2002-05-03 Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation

Country Status (10)

Country Link
US (1) US7034022B2 (fr)
EP (1) EP1503991A1 (fr)
JP (1) JP2005529147A (fr)
AU (1) AU2003246868A1 (fr)
BR (1) BR0304666A (fr)
CA (1) CA2485083A1 (fr)
FR (1) FR2839309B1 (fr)
IL (1) IL164994A0 (fr)
MX (1) MXPA04010129A (fr)
WO (1) WO2003095433A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI9909660B8 (pt) 1998-03-19 2021-05-25 Vertex Pharma compostos inibidores de caspases, composição farmacêutica e uso de ditos compostos
US6242422B1 (en) * 1998-10-22 2001-06-05 Idun Pharmacueticals, Inc. (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
FR2835835B1 (fr) * 2002-02-11 2004-04-16 Aventis Pharma Sa Nouveaux derives de la pyridazine, leur utilisation comme medicaments, compositions pharmaceutiques et leur procede de preparation
US7309701B2 (en) * 2002-11-19 2007-12-18 Sanofi-Aventis Deutschland Gmbh Pyridazinone derivatives as pharmaceuticals and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2003095433A1 (fr) 2003-11-20
US7034022B2 (en) 2006-04-25
JP2005529147A (ja) 2005-09-29
CA2485083A1 (fr) 2003-11-20
BR0304666A (pt) 2004-07-20
AU2003246868A1 (en) 2003-11-11
IL164994A0 (en) 2005-12-18
EP1503991A1 (fr) 2005-02-09
FR2839309A1 (fr) 2003-11-07
US20050171346A1 (en) 2005-08-04
MXPA04010129A (es) 2005-01-25

Similar Documents

Publication Publication Date Title
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
FR2772763B1 (fr) Nouveaux analogues tetracycliques de camptothecines, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
EP1291362A4 (fr) Combinaison d'acide folique et de polysaccharide, son procede de preparation et composition pharmaceutique contenant cette combinaison agissant comme principe actif
FR2820739B1 (fr) Derive d'acide amine et gelifiant, composition de gel et cosmetique le contenant, et procedes de preparation correspondants
MA26675A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
SE0102439D0 (sv) New compounds
CA2400268A1 (fr) Derives de pyrrolopyrimidinone, procedes d'elaboration et d'utilisation
EE200100010A (et) Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis
DK1041072T3 (da) Dioxocyclopentylhydroxamsyrer
EE200100007A (et) Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis
MA26603A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2869611B1 (fr) Derives de l'acide hexenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
FR2757514B1 (fr) Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
NO20010940D0 (no) TAN-1057 derivater
FR2869615B1 (fr) Derives de l'acide butanoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et leurs applications therapeutiques
FR2869610B1 (fr) Derives de l'acide pentenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et leurs applications therapeutiques
FR2839309B1 (fr) Nouveaux derives de l'acide hexahydro-pyridazine-3- carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation
EP1758577A4 (fr) Nouveaux composes, nouvelles compositions pharmaceutiques contenant ces composes et procedes d'utilisation correspondants
MA26863A1 (fr) Nouvelles pyrazolo [4,3-e] diazepines substituées, compositions pharmaceutiques les contenant, leur utilisation comme produits pharmaceutiques et procedes pour leur preparation
NO20055754L (no) Kolkisosidanaloger
WO2001089282A3 (fr) Derives de l'amide de l'acide 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoique
FR2853649B1 (fr) Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2840898B1 (fr) Derives hydrazide ou hydrazone de l'acide hexahydropyridazine-3-carboxylique, chimiotheques et compositions pharmaceutiques les contenant, utilisation comme medicaments, et procede de preparation
FR2786182B1 (fr) Nouveaux derives d'acylguanidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2789078B3 (fr) Derives d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130131